168 related articles for article (PubMed ID: 34667024)
1. A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma.
Angeles CV; Velez A; Rios J; Laxa B; Shum D; Ruiz PD; Shen Y; Ostrovnaya I; Gularte-Mérida R; Nacev BA; Dickson MA; Djaballah H; Okada T; Singer S
Clin Cancer Res; 2022 Jan; 28(1):175-186. PubMed ID: 34667024
[TBL] [Abstract][Full Text] [Related]
2. Restoration of C/EBPα in dedifferentiated liposarcoma induces G2/M cell cycle arrest and apoptosis.
Wu YV; Okada T; DeCarolis P; Socci N; O'Connor R; Geha RC; Joy Somberg C; Antonescu C; Singer S
Genes Chromosomes Cancer; 2012 Apr; 51(4):313-27. PubMed ID: 22170698
[TBL] [Abstract][Full Text] [Related]
3. miR-193b-Regulated Signaling Networks Serve as Tumor Suppressors in Liposarcoma and Promote Adipogenesis in Adipose-Derived Stem Cells.
Mazzu YZ; Hu Y; Soni RK; Mojica KM; Qin LX; Agius P; Waxman ZM; Mihailovic A; Socci ND; Hendrickson RC; Tuschl T; Singer S
Cancer Res; 2017 Nov; 77(21):5728-5740. PubMed ID: 28882999
[TBL] [Abstract][Full Text] [Related]
4. Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability.
Crago AM; Socci ND; DeCarolis P; O'Connor R; Taylor BS; Qin LX; Antonescu CR; Singer S
Clin Cancer Res; 2012 Mar; 18(5):1334-40. PubMed ID: 22241790
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component.
Adachi T; Oda Y; Sakamoto A; Saito T; Tamiya S; Masuda K; Tsuneyoshi M
Int J Surg Pathol; 2001 Apr; 9(2):99-109. PubMed ID: 11484509
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine Combined With Rapamycin Arrests Tumor Growth in a Patient-derived Orthotopic Xenograft (PDOX) Mouse Model of Dedifferentiated Liposarcoma.
Masaki N; Aoki Y; Kubota Y; Obara K; Miyazaki J; Hoffman RM
In Vivo; 2022; 36(6):2630-2637. PubMed ID: 36309387
[TBL] [Abstract][Full Text] [Related]
7. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization.
Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Ikegami H; Ariyoshi A; Naito M; Kaneko Y; Kikuchi M
Int J Oncol; 2003 Mar; 22(3):535-42. PubMed ID: 12579306
[TBL] [Abstract][Full Text] [Related]
8. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
Wang X; Asmann YW; Erickson-Johnson MR; Oliveira JL; Zhang H; Moura RD; Lazar AJ; Lev D; Bill K; Lloyd RV; Yaszemski MJ; Maran A; Oliveira AM
Genes Chromosomes Cancer; 2011 Nov; 50(11):849-58. PubMed ID: 21793095
[TBL] [Abstract][Full Text] [Related]
9. Activation of the Akt-mTOR and MAPK pathways in dedifferentiated liposarcomas.
Ishii T; Kohashi K; Iura K; Maekawa A; Bekki H; Yamada Y; Yamamoto H; Nabeshima K; Kawashima H; Iwamoto Y; Oda Y
Tumour Biol; 2016 Apr; 37(4):4767-76. PubMed ID: 26518767
[TBL] [Abstract][Full Text] [Related]
10. Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma.
Zhang K; Chu K; Wu X; Gao H; Wang J; Yuan YC; Loera S; Ho K; Wang Y; Chow W; Un F; Chu P; Yen Y
Cancer Res; 2013 Feb; 73(4):1298-307. PubMed ID: 23393200
[TBL] [Abstract][Full Text] [Related]
11. Expression of FRS2 in atypical lipomatous tumor/well-differentiated liposarcoma and dedifferentiated liposarcoma: an immunohistochemical analysis of 182 cases with genetic data.
Jing W; Lan T; Qiu Y; Peng R; Lu Y; Chen H; Chen M; He X; Chen C; Zhang H
Diagn Pathol; 2021 Oct; 16(1):96. PubMed ID: 34696768
[TBL] [Abstract][Full Text] [Related]
12. Cyclin C regulates adipogenesis by stimulating transcriptional activity of CCAAT/enhancer-binding protein α.
Song Z; Xiaoli AM; Zhang Q; Zhang Y; Yang EST; Wang S; Chang R; Zhang ZD; Yang G; Strich R; Pessin JE; Yang F
J Biol Chem; 2017 May; 292(21):8918-8932. PubMed ID: 28351837
[TBL] [Abstract][Full Text] [Related]
13. Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets.
Miller ML; Molinelli EJ; Nair JS; Sheikh T; Samy R; Jing X; He Q; Korkut A; Crago AM; Singer S; Schwartz GK; Sander C
Sci Signal; 2013 Sep; 6(294):ra85. PubMed ID: 24065146
[TBL] [Abstract][Full Text] [Related]
14. The transition of tissue inhibitor of metalloproteinases from -4 to -1 induces aggressive behavior and poor patient survival in dedifferentiated liposarcoma via YAP/TAZ activation.
Shrestha M; Ando T; Chea C; Sakamoto S; Nishisaka T; Ogawa I; Miyauchi M; Takata T
Carcinogenesis; 2019 Oct; 40(10):1288-1297. PubMed ID: 31074490
[TBL] [Abstract][Full Text] [Related]
15. FUS-DDIT3 prevents the development of adipocytic precursors in liposarcoma by repressing PPARgamma and C/EBPalpha and activating eIF4E.
Pérez-Mancera PA; Bermejo-Rodríguez C; Sánchez-Martín M; Abollo-Jiménez F; Pintado B; Sánchez-García I
PLoS One; 2008 Jul; 3(7):e2569. PubMed ID: 18596980
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma.
Crago AM; Singer S
Curr Opin Oncol; 2011 Jul; 23(4):373-8. PubMed ID: 21552124
[TBL] [Abstract][Full Text] [Related]
17. The Role of miR-326 in Adipogenic Differentiation of Human Adipose-Derived Stem Cells by Targeting C/EBPα in vitro.
Feng Y; Zhou L; Peng Y; Yang Y; Fan T; Jiang X; Dai J; Ouyang J
Anat Rec (Hoboken); 2020 Jul; 303(7):2054-2060. PubMed ID: 31595632
[TBL] [Abstract][Full Text] [Related]
18. [Retroperitoneal dedifferentiated liposarcomas: semi-quantitative assessment of the dedifferentiated component and prognosis].
Volkov AY; Kozlov NA; Nered SN; Stilidi IS; Stroganova AM; Arkhiri PP; Antonova EY; Privezentsev SA
Arkh Patol; 2020; 82(5):25-32. PubMed ID: 33054029
[TBL] [Abstract][Full Text] [Related]
19. p300 coactivates the adipogenic transcription factor CCAAT/enhancer-binding protein alpha.
Erickson RL; Hemati N; Ross SE; MacDougald OA
J Biol Chem; 2001 May; 276(19):16348-55. PubMed ID: 11340085
[TBL] [Abstract][Full Text] [Related]
20. Adipogenesis induces growth inhibition of dedifferentiated liposarcoma.
Kim YJ; Yu DB; Kim M; Choi YL
Cancer Sci; 2019 Aug; 110(8):2676-2683. PubMed ID: 31069877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
